-19 4 ..65 --19 1,448 RT-PCR --19 4,752 ATK * 1 ( 8 ..65) * 2 () * 3 ( 54 , 81 , 77 ) ( 12 .. 2565, 22 . 2564,) 1. 94 4,992 1,481 2. CLUSTER . 10 116 3. CLUSTER . 6 10 4. 29 5. 27 6. … [+302 chars]
. -19 SARS-CoV-2 SARS-CoV-2 1. -19 2. 3. 48 5-6 90 6 4. 20-30 “-19 -19 -19 -19 Chula-CoV-19 HXP-GPOVac” ..
. -19 SARS-CoV-2 SARS-CoV-2 1. -19 2. 3. 48 5-6 90 6 4. 20-30 “-19 -19 -19 -19 Chula-CoV-19 HXP-GPOVac” ..
“ (Hemophilia)” (Prophylaxis treatment) (Hemophilia) .. 2 .. X 2 Hemophilia A 8 Hemophilia B 9 99 2 (Episodic treatment) (Prophylaxis treatment) 1-2 (non-f… [+69 chars]
“ (Hemophilia)” (Prophylaxis treatment) (Hemophilia) .. 2 .. X 2 Hemophilia A 8 Hemophilia B 9 99 2 (Episodic treatment) (Prophylaxis treatment) 1-2 (non-f… [+69 chars]
4 .. 2565 – -19 1,448 ( RT-PCR) 1. 94 4,992 1,481 2.CLUSTER . 10 116 3.CLUSTER . 6 10 4. 29 5. 27 6. 3 2 1 7. 275 58 68 3 8. () 40 9. 835 4 2565 3 953,606 3 1,653 ( 173.34 ) 1 (0.… [+240 chars]
. -19 SARS-CoV-2 SARS-CoV-2 1. -19 2. 3. 48 5-6 90 6 4. 20-30 “-19 -19 -19 -19 Chula-CoV-19 HXP-GPOVac” ..
... mRNA MMWR (CDC) mRNA 10 16 ..64 7 ..65 -19 -19 1 = 24% 2 = 54% 1 + mRNA 1 = 79% mRNA 3 = 83% -19 1 = 31% 2 = 67% 1 + mRNA 1 = 78% mRNA 3 = 90% CDC 1 2 mRNA 1 2 2 mRNA 100 -19 100 ” “ 1 2… [+1 chars]
27 400 4 - 100 17 3 ..2565 19 (.) 19 58 26,840 3,711,595 23,412 3,427,054 97 25,415 259,126 . 67,795 . HI CI 191,331 1,838 752 309% 97 41 . 18 , 6 , 4 , 3 , 2 1 56 41 4-100 81 98% <ul><li>1.. 3… [+546 chars]
“ (Hemophilia)” (Prophylaxis treatment) (Hemophilia) .. 2 .. X 2 Hemophilia A 8 Hemophilia B 9 99 2 (Episodic treatment) (Prophylaxis treatment) 1-2 (non-f… [+69 chars]
